Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.

Johanna NoelAnne JouinotJérôme AlexandreGuillaume UlmannMarie BretagneZahra Castel-AjgalSixtine De PercinClémentine Vaquin-VillemineyMarie-Pierre RevelMichael PeyromaurePascaline Boudou-RouquetteJennifer ArrondeauIthar GataaJean-Philippe DurandFrançois GoldwasserOlivier Huillard

Published in: Cancers (2022)

Our study identifies an association between mRCC patients' energy expenditure and nivolumab efficacy. The measurement of REE by indirect calorimetry in routine practice could help identify patients at risk of nivolumab failure.

Keyphrases

metastatic renal cell carcinoma
end stage renal disease
ejection fraction
newly diagnosed
healthcare
primary care
peritoneal dialysis
prognostic factors
genome wide
gene expression
clinical practice
patient reported outcomes